Terumo Vietnam, VNHA partner on cardiovascular training
Terumo Vietnam Medical Equipment and the Vietnam National Heart Association (VNHA) have signed a memorandum of understanding on Oct. 7 in Hanoi, to strengthen cardiovascular education and professional development in Vietnam.
Terumo Vietnam and VNHA have formed a partnership to enhance cardiovascular training and education for healthcare professionals in Vietnam. The collaboration will focus on medical education, scientific exchange, and training in various areas such as coronary intervention, vascular closure, complex percutaneous coronary intervention (PCI), complication management, extracorporeal membrane oxygenation (ECMO), critical care, and catheterization laboratory nursing.
Yasuhiro Ikoma, Terumo's Chief Commercial Officer, emphasized that continuous education and knowledge exchange are crucial for improving patient outcomes. Terumo believes that empowering healthcare professionals through continuous learning is essential for advancing cardiovascular practice and enhancing patient care.
Professor Pham Manh Hung, president of VNHA, highlighted the importance of continuous professional development in keeping up with evolving cardiovascular practices. He expressed appreciation for Terumo's commitment to supporting educational initiatives that expand learning opportunities and strengthen clinical expertise for healthcare professionals.
Nguyen Do Bao Chau, General Director of Terumo Vietnam Medical Equipment, stated that the partnership will concentrate on practical training to meet changing clinical needs. By working closely with VNHA, Terumo aims to deliver educational initiatives that support healthcare professionals in adapting to evolving clinical requirements and advancing cardiovascular care across the country.
Established in 1992, VNHA is a nonprofit professional organization dedicated to cardiovascular medicine. It engages in activities such as continuing medical education, research, professional development, and international cooperation. Terumo, a Tokyo-based company, operates in over 160 countries and regions, providing medical technologies for various specialties including vascular intervention, cardiovascular surgery, blood transfusion, and cell therapy.
Written by urgent.news from VnExpress Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.